IBEX (IBEX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual general meeting is scheduled for December 5, 2025, to be held virtually, with shareholders voting on key proposals including board composition, director elections, board vacancy procedures, an amended long-term incentive plan, and auditor appointment.
The proxy statement includes forward-looking statements and outlines risk factors, with references to the company's annual report for further details.
Shareholders of record as of October 10, 2025, are eligible to vote, and the company encourages prompt voting via multiple channels.
Voting matters and shareholder proposals
Proposal 1: Set the maximum number of directors at eight.
Proposal 2: Elect eight director nominees to serve until the next annual meeting or their earlier departure.
Proposal 3: Authorize the board to fill any board vacancy.
Proposal 4: Approve the amended and restated 2020 Long-Term Incentive Plan, increasing the share reserve and updating plan terms.
Proposal 5: Approve Deloitte & Touche LLP as auditor and authorize the audit committee to set remuneration.
The board recommends voting “FOR” all proposals and each director nominee.
Board of directors and corporate governance
The board consists of eight directors, with recent changes due to resignations and appointments, and a transition from controlled company status after TRGI reduced its ownership.
Five of eight directors are independent under Nasdaq standards.
The board values diversity, with 37.5% female and 37.5% racially/ethnically diverse directors.
Three standing committees: Audit, Compensation, and Corporate Governance, with regular meetings and high director attendance.
Prohibition on hedging and pledging company securities for directors and employees.
Latest events from IBEX
- Strong growth, high client retention, and AI-driven expansion define the company's outlook.IBEX
Sidoti March Small-Cap Virtual Conference18 Mar 2026 - Record revenue and EPS growth, raised FY2026 guidance, and strong digital and AI momentum.IBEX
Q2 20265 Feb 2026 - Record financials, margin expansion, and AI-driven growth set up for FY 2025.IBEX
Q4 202420 Jan 2026 - Record Q1 revenue, margin gains, and raised outlook driven by vertical growth and AI innovation.IBEX
Q1 202515 Jan 2026 - Record Q2 revenue, margin expansion, and raised FY25 guidance highlight strong growth momentum.IBEX
Q2 202511 Dec 2025 - Director nominee withdrawal prompts Board to address a new vacancy before the 2025 meeting.IBEX
Proxy Filing5 Dec 2025 - Board commits to simple majority for Bye-Laws changes, enhancing shareholder rights.IBEX
Proxy Filing1 Dec 2025 - Shareholders will vote on board size, director elections, and auditor, with TRGI retaining control.IBEX
Proxy Filing1 Dec 2025 - Independent Nominating Committee formed to enhance board governance and nomination transparency.IBEX
Proxy Filing24 Nov 2025